First clinical utility of sensing Ultrasound Localization Microscopy (sULM): identifying renal pseudotumors.

IF 12.4 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Theranostics Pub Date : 2025-01-01 DOI:10.7150/thno.100897
Sylvain Bodard, Louise Denis, Georges Chabouh, Dany Anglicheau, Olivier Hélénon, Jean-Michel Correas, Olivier Couture
{"title":"First clinical utility of sensing Ultrasound Localization Microscopy (sULM): identifying renal pseudotumors.","authors":"Sylvain Bodard, Louise Denis, Georges Chabouh, Dany Anglicheau, Olivier Hélénon, Jean-Michel Correas, Olivier Couture","doi":"10.7150/thno.100897","DOIUrl":null,"url":null,"abstract":"<p><p><b>Rationale:</b> Renal pseudotumors, which mimic tumors on imaging, pose diagnostic challenges that can lead to unnecessary interventions. Sensing ultrasound localization microscopy (sULM) is an advanced imaging technique that uses ultrasound imaging and microbubbles as sensors to visualize kidney functional units. This study aims to investigate whether sULM could differentiate between renal pseudotumors and tumors based on the presence of glomeruli. <b>Methods:</b> Eleven patients (6 tumors, 6 pseudotumors - 1 patient with 2 pseudotumors) were included. Data on patient demographics, tumor characteristics, and sULM metrics were collected. Glomeruli were quantified and compared among tumors, pseudotumors, and renal cortex using sULM. Additional metrics, i.e., normalized speed and dispersity, were also analyzed. <b>Results:</b> Renal tumors exhibited fewer detected glomeruli paths (mean: 10 ± 6 /cm<sup>2</sup> [range: 4-20]) compared to pseudotumors (26 ± 5 /cm<sup>2</sup> [19-32], p < 0.001) and normal renal cortex (26 ± 6 /cm<sup>2</sup> [15-35], p < 0.01). Tumors displayed lower dispersity (0.13 ± 0.06 arbitrary units [a.u.] [0.07-0.20]) than both the renal cortex (0.3 ± 0.1 a.u. [0.1-0.4], p = 0.0012) and pseudotumors (0.22 ± 0.05 a.u. [0.16-0.25], p = 0.0389), and lower normalized speeds of 0.08 ± 0.04 without units (w.u.) [range: 0.03-0.17] compared to the renal cortex (0.18 ± 0.07 w.u. [0.11-0.28], p = 0.0014) and pseudotumors (0.14 ± 0.02 w.u. [0.12-0.16], p = 0.0497). sULM could effectively differentiate renal pseudotumors from tumors based on glomerular detection and metrics estimation. <b>Conclusion:</b> This initial exploration into the clinical utility of sULM suggests it could provide a noninvasive tool to support patient management, particularly for individuals with contraindications to conventional imaging methods. Further studies are needed to confirm these preliminary findings.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"15 1","pages":"233-244"},"PeriodicalIF":12.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11667240/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.100897","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Renal pseudotumors, which mimic tumors on imaging, pose diagnostic challenges that can lead to unnecessary interventions. Sensing ultrasound localization microscopy (sULM) is an advanced imaging technique that uses ultrasound imaging and microbubbles as sensors to visualize kidney functional units. This study aims to investigate whether sULM could differentiate between renal pseudotumors and tumors based on the presence of glomeruli. Methods: Eleven patients (6 tumors, 6 pseudotumors - 1 patient with 2 pseudotumors) were included. Data on patient demographics, tumor characteristics, and sULM metrics were collected. Glomeruli were quantified and compared among tumors, pseudotumors, and renal cortex using sULM. Additional metrics, i.e., normalized speed and dispersity, were also analyzed. Results: Renal tumors exhibited fewer detected glomeruli paths (mean: 10 ± 6 /cm2 [range: 4-20]) compared to pseudotumors (26 ± 5 /cm2 [19-32], p < 0.001) and normal renal cortex (26 ± 6 /cm2 [15-35], p < 0.01). Tumors displayed lower dispersity (0.13 ± 0.06 arbitrary units [a.u.] [0.07-0.20]) than both the renal cortex (0.3 ± 0.1 a.u. [0.1-0.4], p = 0.0012) and pseudotumors (0.22 ± 0.05 a.u. [0.16-0.25], p = 0.0389), and lower normalized speeds of 0.08 ± 0.04 without units (w.u.) [range: 0.03-0.17] compared to the renal cortex (0.18 ± 0.07 w.u. [0.11-0.28], p = 0.0014) and pseudotumors (0.14 ± 0.02 w.u. [0.12-0.16], p = 0.0497). sULM could effectively differentiate renal pseudotumors from tumors based on glomerular detection and metrics estimation. Conclusion: This initial exploration into the clinical utility of sULM suggests it could provide a noninvasive tool to support patient management, particularly for individuals with contraindications to conventional imaging methods. Further studies are needed to confirm these preliminary findings.

传感超声定位显微镜(sULM)的第一个临床应用:识别肾脏假肿瘤。
理由:肾假瘤在影像学上与肿瘤相似,给诊断带来挑战,可能导致不必要的干预。传感超声定位显微镜(sULM)是一种先进的成像技术,利用超声成像和微泡作为传感器来可视化肾脏功能单位。本研究旨在探讨sULM是否可以根据肾小球的存在来区分肾假瘤和肿瘤。方法:11例患者(肿瘤6例,假瘤6例,假瘤1例)。收集了患者人口统计学、肿瘤特征和sULM指标的数据。用sULM对肿瘤、假肿瘤和肾皮质的肾小球进行量化和比较。还分析了其他指标,即标准化速度和分散性。结果:与假肿瘤(26±5 /cm2 [19-32], p < 0.001)和正常肾皮质(26±6 /cm2 [15-35], p < 0.01)相比,肾肿瘤的肾小球路径较少(平均:10±6 /cm2[范围:4-20])。肿瘤分散度较低(0.13±0.06任意单位[a.u.])。][0.07-0.20])高于肾皮质(0.3±0.1 a.u. [0.1-0.4], p = 0.0012)和假肿瘤(0.22±0.05 a.u. [0.16-0.25], p = 0.0389),且无单位归一化速度0.08±0.04 (w.u.)[范围:0.03-0.17]低于肾皮质(0.18±0.07 w.u. [0.11-0.28], p = 0.0014)和假肿瘤(0.14±0.02 w.u. [0.12-0.16], p = 0.0497)。基于肾小球检测和指标估计,sULM能有效区分肾假瘤和肿瘤。结论:对sULM临床应用的初步探索表明,它可以提供一种非侵入性的工具来支持患者管理,特别是对于那些有常规成像方法禁忌症的患者。需要进一步的研究来证实这些初步发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Theranostics
Theranostics MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
25.40
自引率
1.60%
发文量
433
审稿时长
1 months
期刊介绍: Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信